Purpose To report the unusual association between non-arteritic anterior ischaemic optic neuropathy (NAION) and non-ischaemic central retinal vein occlusion (CRVO) in two patients. Methods Case ...

Deep Parikh, MD, sat down with Emily Kaiser Maharjan from Optometry Times to talk about his presentation at Collaborative ...

Expert Rev Ophthalmol. 2013;8(3):227-235. The use of anti-VEGF is rapidly becoming the standard of care for retinal vascular disease. There remains some concern regarding the duration of treatment ...

The dilemma still holds regarding treatment of the very ischemic central retinal vein occlusion subgroup with ME with profound visual loss. Combination therapy of anti-VEGF agents and a steroid ...

Higher anti-VEGF injection frequency may lead to greater visual acuity gains in patients with retinal vein occlusion.

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

Tofacitinib may be a safe and effective treatment option for older, biologic-naive patients with active ulcerative colitis, according to study results published in Clinical Gastroenterology and ...

High blood pressure can quietly damage your ocular health. Doctor reveals subtle signs to watch out for and preventive tips.

Ninety-nine patients with retinal vein occlusion (40 with central, 59 with branch vein occlusion) were investigated for the prevalence of associated diseases for comparison with an age-matched control ...

lrb.ap-hop-paris.fr AIM To study the effect of superselective ophthalmic artery fibrinolysis as a treatment for central retinal vein occlusion (CRVO). METHODS Retrospective, university based single ...

Objective To indirectly compare aflibercept, bevacizumab, dexamethasone, ranibizumab and triamcinolone for treatment of macular oedema secondary to central retinal vein occlusion using a network ...